Practice guidelines for the management of patients with histoplasmosis

Medicine & Life Sciences

• Histoplasmosis 100%
• Practice Management 89%
• Practice Guidelines 70%
• liposomal amphotericin B 45%
• Amphotericin B 27%
• Guidelines 16%
• Ketoconazole 10%
• Itraconazole 10%
• Therapeutics 9%
• Lung 8%
• Congresses 8%
• Liposomes 8%
• Secondary Prevention 8%
• Infections 7%
• Suspensions 7%
• Cost-Benefit Analysis 7%
• Acquired Immunodeficiency Syndrome 6%
• Immunosuppressive Agents 6%
• Quality of Life 5%
• Costs and Cost Analysis 5%
• Morbidity 4%
• Population 3%